Keyphrases
DNA Vaccination
100%
Vaccination Strategy
100%
Cervical Cancer
100%
Human Papillomavirus DNA
100%
High-risk Human Papillomavirus (HR-HPV)
66%
Tumor
33%
Clinical Application
33%
CD4+ T
33%
CD8+
33%
Cell-mediated Immune Response
33%
Continued Growth
33%
Vaccination
33%
HPV16
33%
Antitumor Effect
33%
Papillomavirus Infections
33%
E7 Antigen
33%
Therapeutic DNA Vaccine
33%
Invariant Chain
33%
Medicine and Dentistry
Wart Virus
100%
DNA Immunization
100%
Cervical Cancer
100%
Neoplasm
50%
T-Helper Cell
25%
Immune Response
25%
Cytotoxic T-Cell
25%
DNA Vaccine
25%
Human Papillomavirus Type 16
25%
Papillomavirus Infection
25%
Pharmacology, Toxicology and Pharmaceutical Science
Vaccination Policy
100%
Uterine Cervix Cancer
100%
Human Papillomavirus
100%
Neoplasm
50%
CD8 Antigen
25%
DNA Vaccine
25%
Human Papillomavirus Type 16
25%
Papillomavirus Infection
25%
Immunology and Microbiology
DNA Vaccination
100%
Wart Virus
100%
Immune Response
20%
T-Helper Cell
20%
Vaccination Policy
20%
Cytotoxic T-Cell
20%
Human Papillomavirus Type 16
20%
DNA Vaccine
20%